K-Ras mutations are changing practice in advanced colorectal cancer

J Natl Cancer Inst. 2008 Dec 3;100(23):1667-9. doi: 10.1093/jnci/djn429. Epub 2008 Nov 25.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / metabolism*
  • Cetuximab
  • Clinical Trials as Topic
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology
  • Drug Labeling
  • ErbB Receptors / drug effects*
  • ErbB Receptors / metabolism
  • Genes, ras*
  • Humans
  • Mutation*
  • Panitumumab
  • Reproducibility of Results

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Panitumumab
  • ErbB Receptors
  • Cetuximab